Suppr超能文献

足细胞病相关的 Nephrin 自身抗体

Autoantibodies Targeting Nephrin in Podocytopathies.

机构信息

From the III. Department of Medicine (F.E.H., S.D., M.L., G.Z., L.S., A.S., O.K., F.G., R.L., L.M.M., E.H., M.M.R., N.M.T., T.B.H.) and the Departments of Medical Biometry and Epidemiology (H.O.P.), Pathology (T.Z., T.W.), Pediatric Nephrology (J.O.), and Obstetrics and Fetal Medicine (A.D.), Hamburg Center for Kidney Health (F.E.H., S.D., M.L., G.Z., L.S., A.S., O.K., F.G., R.L., L.M.M., J.O., E.H., M.M.R., N.M.T., T.B.H.), and the Hamburg Center for Translational Immunology (N.M.T., T.B.H.), University Medical Center Hamburg-Eppendorf, Hamburg, and the Center for Pediatrics and Adolescent Medicine, University Hospital Heidelberg, Heidelberg (F.S.) - all in Germany; the Department of Biomedicine, Aarhus University, Aarhus, Denmark (F.D., A.M.B., M.M.R.); the Department of Precision and Regenerative Medicine and Ionian Area, Nephrology, Dialysis, and Transplantation Unit, University of Bari Aldo Moro, Bari (A.M., P.P., L.G.), and the Division of Nephrology, Bambino Gesù Children's Hospital, IRCCS, Rome (M.C., F.E., M.V.) - both in Italy; INSERM, Unité Mixte de Recherche S 1155, Sorbonne Université (H.D., P.R.), and the Pediatric Nephrology Department, Robert Debré Hospital, Assistance Publique-Hôpitaux de Paris (C.D., J.H.), Paris, and the Division of Nephrology, Centre Hospitalier du Mans, Le Mans (P.R.) - all in France; the Center for Clinical and Translational Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, and the Department of Pediatrics, Ohio State University College of Medicine - both in Columbus (W.E.S.); the Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School - both in Boston (A.W.); and the Department of Medicine, Johns Hopkins University School of Medicine, Baltimore (N.A.).

出版信息

N Engl J Med. 2024 Aug 1;391(5):422-433. doi: 10.1056/NEJMoa2314471. Epub 2024 May 25.

Abstract

BACKGROUND

Minimal change disease and primary focal segmental glomerulosclerosis in adults, along with idiopathic nephrotic syndrome in children, are immune-mediated podocytopathies that lead to nephrotic syndrome. Autoantibodies targeting nephrin have been found in patients with minimal change disease, but their clinical and pathophysiological roles are unclear.

METHODS

We conducted a multicenter study to analyze antinephrin autoantibodies in adults with glomerular diseases, including minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, IgA nephropathy, antineutrophil cytoplasmic antibody-associated glomerulonephritis, and lupus nephritis, as well as in children with idiopathic nephrotic syndrome and in controls. We also created an experimental mouse model through active immunization with recombinant murine nephrin.

RESULTS

The study included 539 patients (357 adults and 182 children) and 117 controls. Among the adults, antinephrin autoantibodies were found in 46 of the 105 patients (44%) with minimal change disease, 7 of 74 (9%) with primary focal segmental glomerulosclerosis, and only in rare cases among the patients with other conditions. Of the 182 children with idiopathic nephrotic syndrome, 94 (52%) had detectable antinephrin autoantibodies. In the subgroup of patients with active minimal change disease or idiopathic nephrotic syndrome who were not receiving immunosuppressive treatment, the prevalence of antinephrin autoantibodies was as high as 69% and 90%, respectively. At study inclusion and during follow-up, antinephrin autoantibody levels were correlated with disease activity. Experimental immunization induced a nephrotic syndrome, a minimal change disease-like phenotype, IgG localization to the podocyte slit diaphragm, nephrin phosphorylation, and severe cytoskeletal changes in mice.

CONCLUSIONS

In this study, circulating antinephrin autoantibodies were common in patients with minimal change disease or idiopathic nephrotic syndrome and appeared to be markers of disease activity. Their binding at the slit diaphragm induced podocyte dysfunction and nephrotic syndrome, which highlights their pathophysiological significance. (Funded by Deutsche Forschungsgemeinschaft and others.).

摘要

背景

微小病变病和成人局灶节段性肾小球硬化症,以及儿童特发性肾病综合征,都是导致肾病综合征的免疫介导性足细胞病。在微小病变病患者中发现了针对足细胞裂孔隔膜蛋白的自身抗体,但它们的临床和病理生理作用尚不清楚。

方法

我们进行了一项多中心研究,分析了包括微小病变病、局灶节段性肾小球硬化症、膜性肾病、IgA 肾病、抗中性粒细胞胞质抗体相关性肾小球肾炎和狼疮性肾炎在内的成人肾小球疾病患者、特发性肾病综合征患儿以及对照组患者的抗足细胞裂孔隔膜蛋白自身抗体。我们还通过用重组鼠足细胞裂孔隔膜蛋白主动免疫来创建实验性小鼠模型。

结果

该研究纳入了 539 名患者(357 名成人和 182 名儿童)和 117 名对照。在成人中,在 105 例微小病变病患者中有 46 例(44%)、74 例局灶节段性肾小球硬化症患者中有 7 例(9%)检测到抗足细胞裂孔隔膜蛋白自身抗体,而在其他疾病患者中仅偶尔发现。在 182 例特发性肾病综合征患儿中,有 94 例(52%)检测到抗足细胞裂孔隔膜蛋白自身抗体。在未接受免疫抑制治疗的活动期微小病变病或特发性肾病综合征患者亚组中,抗足细胞裂孔隔膜蛋白自身抗体的患病率分别高达 69%和 90%。在研究纳入时和随访期间,抗足细胞裂孔隔膜蛋白自身抗体水平与疾病活动度相关。实验性免疫接种可诱导小鼠发生肾病综合征、微小病变病样表型、IgG 定位于足细胞裂孔隔膜、足细胞裂孔隔膜蛋白磷酸化和严重的细胞骨架改变。

结论

在这项研究中,循环抗足细胞裂孔隔膜蛋白自身抗体在微小病变病或特发性肾病综合征患者中很常见,似乎是疾病活动的标志物。它们在裂孔隔膜上的结合诱导了足细胞功能障碍和肾病综合征,这突出了它们的病理生理意义。(由德国研究基金会等资助)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验